Authors
Latest:
Engaging with Emotions: Patients as PartnersInvolving patients more meaningfully in the industry's activities means getting more serious about their emotional wellbeing.
Latest:
The Quality CoachThe right person can successfully promote proper management of quality and compliance, leading to desired clinical trial outcomes.
Latest:
Biomarker BoomA look at the different testing methods and how the results impact drug development.
Latest:
Introducing PALADINFirst-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Latest:
Adaptive Designs: A Fad or the Future of Clinical Research?Making adaptations to clinical trials in the early stages of research with the use of interim data.
Latest:
Critical Appraisal of Clinical Quality Assurance Based on Benchmarking Results: Past - Present - FutureA follow-up survey on clinical quality assurance (CQA) assesses current industry best practices compared to a decade ago, and provides recommendations on this key component of quality management for the future.
Latest:
East vs WestHow cultural and training differences affect molecular-based clinical research in China.
Latest:
Three Generations of RTSM (Randomization and Trial Supply Management)With all the focus on various data capture solutions in the clinical trials world over the past decade(s), few people seem to have noticed the exponential advances made in the real workhorse systems of the trials: RTSM. Also known as IVR, IWR and IRT, these systems actually execute randomization, blinded supply and resupply management to depots and sites, and most importantly of all, drug dispensing. Is there anything more important to get right?
Latest:
Adaptive Designs: A Fad or the Future of Clinical Research?Making adaptations to clinical trials in the early stages of research with the use of interim data.
Latest:
Approaching AfricaThe Declaration of Helsinki requires that control groups receive the “best” current treatment, not the “local” one. This shift in wording has profound implications.
Latest:
Pharma Casts Out Financial FunctionsOutsourcing finance and accounting can provide cost savings and improve operations.
Latest:
Pediatric Research in GermanySurveys among pharma, clinics, and investigators shed light on trials in children.
Latest:
Risk Based BudgetingAdoption of the concept of Risk-Based Budgeting could help maintain the trial budget or even save the whole clinical trial.
Latest:
How NLP Surfaces Adverse Events and Safety Insights to Improve Drug Safety ProcessesUse cases show benefits of unlocking data to improve signal and adverse event detection.
Latest:
Three Must-Dos for Tracking Research and Development of Monoclonal AntibodiesThere is an expanding array of potential antibody-based treatment options, such as bispecific or multispecific antibodies, that show promise in addressing conditions such as cancer, engineered antibody fragments, or even antibody-drug conjugates.
Latest:
Harnessing the Power of Scientific SurveillanceStatistical methods used via this technique in centralized monitoring.
Latest:
Considering Patient Burden in OncologyImplementing new strategies with the use of patient-reported outcomes.
Latest:
Virtual Medical Affairs Audits: A Viable AlternativeVirtual audits proving to be beneficial post-COVID despite continuing challenges.
Latest:
Facilitating Adoptive Cell Therapy Clinical TrialsEvolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity.
Latest:
eCOA Studies: Tackling the Barriers to Adopting ‘Bring Your Own Device’ StrategiesAn increasing number of patients report looking for more simplicity and less burden related to a clinical trial, and a "bring your own device" option is one of the ways to meet this need
Latest:
Clinical Study Audits: The Quality Management ApproachAdvancing risk-based auditing one step further by identifying the underlying process deficiencies to enable improved corrective and preventive actions.
Latest:
Real-World Use of an Artificial Intelligence-Supported Solution for Coding of Adverse Events in Clinical TrialsStudy evaluates the use of AI-supported medical coding module.
Latest:
Bringing AI Out of the Shadows and into the Physical World of Drug DevelopmentWhile many groups rely on manual chemistry processes, innovative platforms have emerged that allow these protocols to be executed on custom automation systems.
Latest:
The Use of Artificial Intelligence in Clinical Trial EnrollmentIn an interview with Applied Clinical Trials Associate Editor Don Tracy, Sonia Lwoff, director, clinical operations, Rho, discusses the potential for artificial intelligence in clinical trial decision-making and enrollment.
Latest:
Facilitating Adoptive Cell Therapy Clinical TrialsEvolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity.
Latest:
The Current Status of European Research Related to COVID-19: The EUCROF PerspectiveSuccessful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
Latest:
Preparing for Pivotal: Solving Challenges in Scale for Cell and Gene Therapy Clinical TrialsTuesday, June 22, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST
